诊断神经病理学半个世纪的变迁:从昔日巨匠到当前脑肿瘤分类
本文以《Human Pathology》创刊号中对《麻省总医院神经临床病理讨论会》的述评性综述为起点,回顾过去半个世纪神经病理诊断的演变。当年讨论者虽为杰出诊断专家,但受当时方法所限;后续新技术使下一代专家获得新见解。当今病理学家诊断技能同样娴熟,但诊断更多基于活检而非尸检,并借助术前影像与术后分子分析。结论是即便面临人工智能与深度分子分析等颠覆性创新,仍将持续需要病理学家及其他临床诊断专家的专业知识。
要点
- 诊断神经病理学半个世纪以来从依赖尸检与经典组织学转向活检结合术前影像和术后分子分析。
- 历代诊断专家均受限于当时可用方法,新技术推动下一代专家获得新见解。
- 即便人工智能与深度分子分析等颠覆性创新出现,病理学家专业知识仍不可或缺。
核心结论
- 过去半个世纪神经病理诊断方法从尸检为主转向活检结合影像与分子分析。
- 历代诊断专家均受限于当时技术条件,新技术推动诊断见解更新。
- 即使面临人工智能与深度分子分析等颠覆性创新,仍需要病理学家等临床诊断专家的专业知识。
研究设计与样本
- 本文为综述,以《Human Pathology》创刊号中对《麻省总医院神经临床病理讨论会》一书的述评性综述为起点展开回顾。
- 每个患者病史由知名神经内科、神经外科和神经病理学家讨论。
主要发现
- 当年病例讨论者虽为杰出诊断专家,但受当时可用方法限制。
- 后续新技术为下一代专家提供了获得新见解的机会。
- 当今病理学家诊断技能同样娴熟,但诊断更多基于活检而非尸检。
- 当今诊断还借助术前影像研究和术后分子分析。
临床怎么用
- 病理诊断应结合术前影像与术后分子分析等辅助信息。
- 应认识到诊断方法随技术演进而变化,保持对新技术的开放态度。
- 即使人工智能等新技术出现,病理学家的专业判断仍应作为诊断核心。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The first issue of Human Pathology contains a laudatory review of one of the most treasured books in the history of neuropathology: Neurological Clinicopathological Conferences of the Massachusetts General Hospital, a collection of neurological cases that appeared first in the New England Journal of Medicine in the 1940s, 1950s, and 1960s. Each patient history is discussed by well-known neurologists, neurosurgeons, and neuropathologists. Review of these cases provides a framework to explore diagnostic shifts that have occurred over the past half century. Importantly, while the discussants of these cases were great diagnosticians, they were somewhat limited by the methods available to them at the time; subsequent novel technologies provided opportunities for new insights that were made by the next generation of experts. Today's pathologists (whether neuropathologists or any other pathology subspecialists) are similarly skilled at diagnosis, although their diagnoses are now more often made on biopsies (rather than autopsies) and informed by pre-operative imaging studies as well as post-operative molecular analyses. In turn, one would conclude that, even in the face of future technological changes brought about by disruptive innovations like artificial intelligence and deep molecular analyses, a need will continue for the expertise of pathologists and other clinical diagnosticians.
引用
- Louis DN. A half century of change in diagnostic neuropathology: from the giants of yore to current brain tumor classification. Hum Pathol. 2019. PMID: 31302204. doi:10.1016/j.humpath.2019.06.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。